drugset / Trial / NCT02658448

GTx-024 as a Treatment for Stress Urinary Incontinence in Women

NCT02658448

Phase 2 Completed 19 enrolled GTx
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether GTx-024 is safe and effective in the treatment of stress urinary incontinence in postmenopausal women.

Timeline

Start
2016-01
Primary completion
2018-06
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Enobosarm Small molecule 3 mg